New components of the renin-angiotensin system: Alamandine and the Mas-related G protein-coupled receptor D

Current Hypertension Reports

Volumn 16, Issue 6, 2014, Pages

  Etelvino, Gisele Maia ^a   Peluso, Antônio Augusto Bastos ^a   Santos, Robson Augusto Souza ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin A; Angiotensin II; Angiotensin (1 12); Angiotensin (1 7); Hypertension; Mas1

Indexed keywords

ALANINE; ALLAMANDIN; ANGIOTENSIN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANTIHYPERTENSIVE AGENT; MAS RELATED G PROTEIN COUPLED RECEPTOR D; UNCLASSIFIED DRUG; ALAMANDINE; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANGIOTENSIN II; G PROTEIN COUPLED RECEPTOR; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

ANTIHYPERTENSIVE ACTIVITY; DECARBOXYLATION; DRUG RECEPTOR BINDING; HEART MUSCLE FIBROSIS; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION; CARDIOVASCULAR DISEASES; DRUG EFFECTS; HUMAN; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ANGIOTENSIN I; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, G-PROTEIN-COUPLED; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84901738820     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0433-0     Document Type: Review

References (53)

1. Belova LA. Angiotensin II-generating enzymes. Biochemistry. 2000;65(12):1337-45. (Pubitemid 33658042)
2. Neves LA, Almeida AP, Khosla MC, Campagnole-Santos MJ, Santos RA. Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res. 1997;30:801-9. (Pubitemid 127519600)
3. Timmermans PB, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens. 1992;5:221S-35.
4. • Carey RM. Newly discovered components and actions of the renin-angiotensin system. Hypertension. 2013;62(5):818-22. This brief review describes the main characteristics of novel components of the renin-angiotensin system.
5. Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, van Kats JP, Saxena PR, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation. 2004;109:2296-301. (Pubitemid 38656868)
6. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11-34. (Pubitemid 30127593)
7. Rompe F, Artuc M, Hallberg A, Alterman M, Ströder K, Reichenbach A, et al. Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kB. Hypertension. 2010;55:924-31.
8. Wong C, Hart SD, Timmermans PBMWM, Smith D. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (All-i) and PD1 231 77 (All-2). J Pharmacol Exp Ther. 1976;584-92.
9. Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277:14838-43. (Pubitemid 34952556)
10. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension. 1998;31:362-7.
11. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993;52:1461-80.
12. Santos RA, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7): an update. Regul Pept. 2000;91:45-62.
13. Ferreira AJ, Santos RA, Almeida AP. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension. 2001;38:665-8.
14. Ferreira AJ, Santos RAS. Cardiovascular actions of angiotensin-(1-7). Braz J Med Biol Res. 2005;38:499-507. (Pubitemid 40703878)
15. Grobe JL, Mecca AP, Mao H, Katovich MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H2417-23. (Pubitemid 43846070)
16. Giani JF, Mayer MA, Muñoz MC, Silberman EA, Höcht C, Taira CA, et al. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab. 2009;296:E262-71.
17. Santos SHS, Fernandes LR, Mario EG, Ferreira AVM, Pôrto LCJ, Alvarez-Leite JI, et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes. 2008;57:340-7.
18. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, et al. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res. 2007;67:2809-15. (Pubitemid 46548970)
19. Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, et al. Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. Prostate. 2013;73:71-82.
20. Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003;100:8258-63. (Pubitemid 36842532)
21. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K. Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun. 2006;350:1026-31. (Pubitemid 44596223)
22. Jessup JA, Trask AJ, Chappell MC, Nagata S, Kato J, Kitamura K, et al. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol. 2008;294:H2614-8.
23. Trask AJ, Jessup JA, Chappell MC, Ferrario CM. Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart. Am J Physiol Heart Circ Physiol. 2008;27157:2242-7.
24. Ferrario CM, Varagic J, Habibi J, Nagata S, Kato J, Chappell MC, et al. Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy. Am J Physiol Heart Circ Physiol. 2009;H1184-92.
25. Ahmad S, Simmons T, Varagic J, Moniwa N, Chappell MC, Ferrario CM. Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue. PLoS ONE. 2011;6:e28501.
26. Ahmad S, Varagic J, Westwood BM, Chappell MC, Ferrario CM. Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes. PLoS ONE. 2011;6:e15759.
27. • Chan KH, Chen YH, Zhang Y, Wong YH, Dun NJ. Angiotensin-[1-12] interacts with angiotensin type I receptors. Neuropharmacology. Elsevier Ltd; 2013;1-7. This report suggests that some biological actions of the new member of renin-angiotensin system, angiotensin-(1-12), can be mediated by a direct interaction with AT1R.
28. Jankowski V, Vanholder R, van der Giet M, Tölle M, Karadogan S, Gobom J, et al. Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol. 2007;27:297-302. (Pubitemid 46143043)
29. Yang R, Smolders I, Vanderheyden P, Demaegdt H, Van Eeckhaut A, Vauquelin G, et al. Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent. Hypertension. 2011;57:956-64.
30. Coutinho DC, Foureaux G, Rodrigues KD, Salles RLA, Moraes PL, Murça TM, et al. Cardiovascular effects of angiotensin A: a novel peptide of the renin-angiotensin system. J Renin Angiotensin Aldosterone Syst. 2013;1-7.
31. •• Lautner RQ, Villela DC, Fraga-Silva RA, Silva N, Verano-Braga T, Costa-Fraga F, et al. Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res. 2013;112:1104-11. This study reported the discovery of a novel peptide of the renin-angiotensin system, alamandine. Evidence that the Mas-related G protein-coupled receptor D (MrgD) is a receptor for alamandine was also provided.
32. Paula RD, Lima CV, Britto RR, Santos MJC, Khosla MC, Santos RAS. Potentiation of the hypotensive effect of bradykinin by. Peptides. 1999;20:493-500.
33. Marques FD, Ferreira AJ, Sinisterra RDM, Jacoby BA, Sousa FB, Caliari MV, et al. An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension. 2011;477-83.
34. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell. 2001;106:619-32. (Pubitemid 32879323)
35. Zylka MJ, Dong X, Southwell AL, Anderson DJ. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci U S A. 2003;100:10043-8. (Pubitemid 37087065)
36. Shinohara T, Harada M, Ogi K, Maruyama M, Fujii R, Tanaka H, et al. Identification of a G protein-coupled receptor specifically responsive to beta-alanine. J Biol Chem. 2004;279:23559-64. (Pubitemid 38685669)
37. Zhang L, Taylor N, Xie Y, Ford R, Johnson J, Paulsen JE, et al. Cloning and expression of MRG receptors in macaque, mouse, and human. Brain Res Mol Brain Res. 2005;133:187-97. (Pubitemid 40248409)
38. Milasta S, Pediani J, Appelbe S, Trim S, Wyatt M, Cox P, et al. Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Mol Pharmacol. 2006;69(2):479-91. (Pubitemid 43121945)
39. Zhang R, Yan P-K, Zhou C-H, Liao J-Y, Wang M-W. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists. Acta Pharmacol Sin. 2007;28:125-31. (Pubitemid 46046636)
40. Crozier RA, Ajit SK, Kaftan EJ, Pausch MH. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci. 2007;27:4492-6. (Pubitemid 46640701)
41. Gembardt F, Grajewski S, Vahl M, Schultheiss H-P, Walther T. Angiotensin metabolites can stimulate receptors of the Mas-related genes family. Mol Cell Biochem. 2008;319:115-23.
42. Rau KK, McIlwrath SL, Wang H, Lawson JJ, Jankowski MP, Zylka MJ, et al. Mrgprd enhances excitability in specific populations of cutaneous murine polymodal nociceptors. J Neurosci. 2009;29:8612-9.
43. Wang H, Zylka MJ. Mrgprd-expressing polymodal nociceptive neurons innervate most known classes of substantia gelatinosa neurons. J Neurosci. 2009;29:13202-9.
44. Nishimura S, Uno M, Kaneta Y, Fukuchi K, Nishigohri H, Hasegawa J, et al. MRGD, a MAS-related G-protein coupled receptor, promotes tumorigenisis and is highly expressed in lung cancer. PLoS ONE. 2012;7:e38618.
45. Bockaert J, Pin JP.Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999;18(7):1723-9. (Pubitemid 29158516)
46. Glusman G, Yanai I, Rubin I, Lancet D. The complete human olfactory subgenome. Genome Res. 2001;11:685-702. (Pubitemid 32447857)
47. Uno M, Nishimura S, Fukuchi K, Kaneta Y, Oda Y, Komori H, et al. Identification of physiologically active substances as novel ligands for MRGPRD. J Biomed Biotechnol. 2012;2012:816159.
48. Silva DMR, Vianna HR, Cortes SF, Campagnole-Santos MJ, Santos RAS, Lemos VS. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides. 2007;28:702-7. (Pubitemid 46204993)
49. Herath CB, Mak K, Burrell LM, Angus PW. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver. Am J Physiol Gastrointest Liver Physiol. 2013;304:G99-108.
50. Kluskens LD, Nelemans SA, Rink R, de Vries L, Meter-Arkema A, Wang Y, et al. Angiotensin-(1-7) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1-7) analog. J Pharmacol Exp Ther. 2009;328(3):849-54.
51. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, et al. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 1990;38(3):370-7. (Pubitemid 20291576)
52. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663-7.
53. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12:70-88. (Pubitemid 36700689) Nível Superior